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Abstract
Background: Quality-adjusted life years (QALY) is a single value index that quantifies the overall burden of disease.
It reflects all aspects of heath, including nonfatal illness and mortality outcomes by weighting life-years lived with
health-related quality of life (HRQOL) scores. This study examine the burden of disease due to increasing levels of
depressive symptoms by examining the association between the 9-item Patient Health Questionnaire (PHQ-9)
scores and QALY for U.S. adults aged 65 years and older.
Methods: We ascertained respondents’ HRQOL scores and mortality status from the 2005–2006, 2007–2008, and
2009–2010 cohorts of the National Health and Nutrition Examination Survey (NHANES) with mortality follow-up
data through December 31, 2011. This analysis included respondents aged 65 years and older (n = 3,680). We
estimated the mean QALY throughout the remaining lifetime according to participants’ depression severity
categories: none or minimal (PHQ-9 score 0–4), mild (5–9), moderate (10–14), and moderately severs and severe
(15 or higher). We estimated QALY loss due to major depressive disorder (PHQ-9 score 10 or higher) and to mild
depression (5–9).
Results: The QALY for persons with none/minimal, mild, moderate, and moderately severe/severe depression were
14.0, 7.8, 4.7, and 3.3 years, respectively. Compared to persons without major depressive disorder, persons with
major depressive disorder had 8.3 fewer QALY (12.7 vs. 4.4), or a 65% loss. Compared to persons who reported
“none” or minimal depressive symptoms, persons who reported mild depressive symptoms had 6.2 fewer QALY
(14.0 vs. 7.8), or a 44% loss. The same patterns were noted in demographic and socioeconomic subgroups and
according to number of comorbidities.
Conclusions: This study not only confirmed the significant burden of disease for major depressive disorder among
the U.S. elderly, but also showed an incremental decrease in QALY with an increasing severity of depressive
symptoms as well as significant QALY loss due to mild depression. Specifically, individuals with higher (or more
impaired) PHQ-9 scores had significantly fewer QALYs and our findings of fewer years of QALY for persons with
major depressive disorder and mild depression were not only statistically significant but also clinically important.
Keywords: Quality-adjusted life year (QALY), Health-related quality of life (HRQOL), Burden of disease, Depression,
Major depressive disorder (MDD)
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Background
Depression is a prevalent condition and is an important
public health problem in the United States [1–3]. In
large nationally representative surveys the prevalence of
depression was estimated to be 6.7% in the past
12 months and 16.6% over a lifetime [4]. Depression
often is associated with other comorbid conditions and
may worsen their health outcomes [5]. Depression can
also be life threatening and has been associated with excess mortality and substantially lower life expectancy [6,
7]. In a recent study of the U.S. adult population, individuals with depression lost a remarkable 16.4 years of
life relative to those without depression [7].
In the United States and throughout the rest of the
world, depression has been considered to be an important contributor to the burden of disease. The Global
Burden of Disease Study estimated disability-adjusted
life years (DALYs) worldwide and found that depression
was the leading health condition worldwide in terms of
DALYs, contributing 917 DALY per 100,000 persons annually [8]. Jia and colleagues estimated quality-adjusted
life expectancy (QALE) for U.S. adults and found that
depression led to a 28.9-year QALE loss at age 18, a
number that greatly exceeded the QALE loss for many
other chronic conditions and risky lifestyle behaviors
such as smoking and physical inactivity [7].
In the elderly, reports of the prevalence of depression
among the non-institutional population range from approximately 8 to 16% [9]. At age 65, those with major
depressive disorder lost 13.8 years of QALE [7]. Understanding the depression associated burden of disease
would be particularly important in the elderly, given that
the number of persons 65 and older in the United States
is projected to nearly double between 2012 and 2050
and depression is more common among persons with
chronic conditions and functional limitations [10, 11].
Depression may be more difficult to detect in the elderly
due to a different clinical presentation and a greater likelihood to present in the context of these comorbid medical conditions [3]. Additionally, population-based
studies have indicated that mean psychological distress
symptoms have not decreased over time, despite increasing use of health services [12]. With regard to treatment,
older depressed patients may be undertreated compared
with younger adults [13]. Yet, over 80% of elderly depressed outpatients without significant comorbid medical illness or dementia who are optimally treated may
recover and remain well during follow-up [9, 14].
Like many other chronic conditions, the severity of depression can range from mild to moderate to severe [15,
16]. Clinicians and investigators have constructed different definitions of depression and administered a variety
of different instruments for surveillance and diagnosis
[15, 17]. For example, the 9-item Patient Health
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Questionnaire (PHQ-9) is a valid diagnostic and severity
measure for depressive disorder in large clinical studies
and for tracking depression prevalence in representative
surveys of the U.S. general population [15]. The PHQ-9
consists of the nine criteria from which the diagnosis of
depressive disorders is based [16]. Major depressive disorder (MDD) or clinical depression is defined as a score
of 10 or higher [15]. The PHQ-9 cut-off of 10 for MDD
includes moderate, moderately severe, and severe depression. By contrast, mild depression is considered to
be a PHQ-9 score of between 5 and 9. The majority of
persons characterized with depressive symptoms have
mild depression and, for this group, the recommendation is watchful waiting and reassessment for antidepressant treatment or psychotherapy after three months [15].
For The Global Burden of Disease Study, the investigators specified that mental disorders had to meet the
threshold for a case according to criteria described in
the Diagnostic and Statistical Manual of Mental Disorders (DSM) or the International Classification of Diseases (ICD) [8, 18]. Although the Global Burden of
Disease study modeled different severity levels for DSM
or ICD diagnosed depression, this study did not examine
the incremental impact of different severity levels or estimate the burden of disease for persons with mild
depression.
The main goal of the current study is to estimate the
burden of disease attributable to different levels of depressive symptoms for U.S. adults aged 65 years and
older. Specifically, we estimated mean quality-adjusted
life years (QALY) throughout the remaining lifetime according to respondents’ PHQ-9 scores, and, by doing so,
we estimated the decreases in QALY (i.e., QALY loss)
for those with major depressive disorder (MDD) as compared to those without MDD, and for those with mild
depressive symptoms as compared to those with none or
minimal depressive symptoms. We also estimated the
QALY losses due to MDD and to mild depression according to demographic and socioeconomic subgroups
and according to number of comorbidities.

Methods
Quality-adjusted life years (QALY) is a single value index
that quantifies the burden of disease. It reflects all aspects of heath, including nonfatal illness and mortality
outcomes, by weighting life-years lived with preferencebased health-related quality of life (HRQOL) scores [19].
Preference-based HRQOL, also called health utility
value, is a summary score that assesses the values of one
health state vs. another state. The health utility value is
anchored at 0 for death and 1 for perfect health, so one
year lived in a reduced health state of utility value of 0.5
is equal to 0.5 QALYs, the same as lived one half year in
perfect health [19]. In this analysis, we calculated mean
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QALY throughout the remaining lifetime for participants
according to their PHQ-9 scores.
Data

We ascertained respondents’ HRQOL scores and mortality status from the 2005–06, 2007–08, and 2009–2010
cohorts of the National Health and Nutrition Examination Survey (NHANES) Linked Mortality File [20, 21].
The NHANES is an ongoing survey of random samples
from the non-institutionalized civilian population of the
U.S. [20]. With the use of the design weight and adjustment for noncoverage and nonresponse, the distribution
of respondents was representative of the U.S. general
population [20]. The NHANES Linked Mortality File
was created by the National Center for Health Statistics
(NCHS) by linking the NHANES respondents to the National Death Index (NDI) [21]. The respondents in this
analysis had mortality follow-up through December 31,
2011. We included only respondents aged 65 years and
older at the baseline, yielding a total sample size of
3,680.
Measures

The NHANES has included the PHQ-9 since the 2005–
2006 cohort [20]. The PHQ-9 asks questions about the
frequency of symptoms of depression over the past two
weeks. In the PHQ-9 response categories “not at all,”
“several days,” “more than half the days,” and “nearly
every day” are given a score ranging from 0 to 3. A total
score is calculated ranging from 0 to 27. The PHQ-9 can
be used to classify depressive symptoms into five severity
categories: none or minimal (0–4), mild (5–9), moderate
(10–14), moderately severe (15–19), and severe (20–27)
[15]. Major depressive disorder (MDD) is defined as having a PHQ-9 score of 10 or higher and mild depression
is defined as having a PHQ-9 score of 5–9 [15].
The NHANES asks respondents to rank their general
health from 1 (excellent) to 5 (poor) and to report numbers of their physically unhealthy days, mentally unhealthy days, and days with activity limitation during the
past 30 days [22]. This study employs a previously constructed mapping algorithm based on respondents’ age
and answers to these four questions to obtain values of a
frequently used preference-based HRQOL measurement,
the EQ-5D index, to calculate QALY [23]. This algorithm provides valid estimates of EQ-5D scores for respondents [23, 24], and the bias of estimated scores has
been estimated to be less than 1% of that using the actual EQ-5D questions [24].
The NHANES includes information on respondent
sociodemographic characteristics and certain diseases at
the baseline [20]. These variables were included in the
analyses of the depression outcome to assess potential
associations with these variables. The analysis examined
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age, gender, race/ethnicity, education achievement, income, marital status, and number of comorbidities. The
NHANES calculated respondents’ family income to the
Federal Poverty Level (FPL) ratio. We used 138% FPL,
the Medicaid income eligibility limit, as the cut-off point
for income.
Statistical analysis

Calculation of mean QALY throughout the remaining
lifetime is difficult because most of the participants were
alive at the end of follow-up [25]. It requires extrapolating quality-adjusted survival time beyond the end of
follow-up. This study proposed and applied a hybrid
method that calculated QALY from two parts: QALY
during the follow-up period (to December 31, 2011) and
QALY beyond the follow-up period (after December 31,
2011). Details of this method were described previously
[25]. To summarize: QALY during the follow-up period
was estimated based on the Kaplan-Meier method [25,
26]. Let L be the time of the end of follow-up and 0 <
t1 ≤ t2 ≤ … ≤ tl < L be times when deaths occurred. Suppose ŜKM(t) is the Kaplan-Meier estimated survival func^ ðt i Þ,
tion. We calculate mean QALY at t i ði ¼ 1; …; lÞ; Q
^ ðLÞ , for who
for those who died at ti; and at time L, Q
were alive at the end of follow-up. QALYs for time
period (0, L] was estimated as:
"
#
l
X
 
 
 
^
^
^
^ ðLÞS^ K M ðt l Þ;
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where t0 = 0 and S(t0) = S(0) = 1.
The QALY beyond the follow-up period was estimated
by extrapolating survival time beyond the end of followup. Because the model usually fits data well during the
early follow-up but does not fit data well near the end of
the follow-up, the model may not extrapolate the survival function well in the tail [27]. Instead, we used the
parametric method to estimate total expected life-years
and the Kaplan-Meier method to estimate life-years
from time 0 to L. We used the Weibull model, Sp(t) =
exp[−(t/λ)β] and the QALYs in the tail was estimated as:
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X
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t−1 −x
where Γ(t) = ∫∞
e dx is the Gamma function.
0x
The QALY loss due to MDD was defined as the difference in QALY for participants without MDD and for
participants with MDD [7, 25]. Similarly, the QALY loss
due to mild depression was defined as the difference in
QALY for participants who reported none or minimal
depressive symptoms (PHQ-9 scores of 0–4) and for
participants with mild depression. A propensity score
method was used to account for the systematic
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difference in participants’ characteristics, such as age
and sex, between those with different levels of depressive
symptoms [28].

Results
The average age of the population was 73.3 years (SD =
5.7 years) at the baseline (Table 1). Women comprised
55% of the population and non-Hispanic whites comprised 84% of the population. Only 8% were nonHispanic blacks and 6% were Hispanics. In this population, the mean EQ-5D score was 0.827 (Table 2). About
12.6% of participants died during the follow-up, yielding
Table 1 Baseline Characteristic, 2005–2010 NHANES
Number

Percenta

S.E.

Total

3,680

100.0%

-

Age: mean (SD)

3,680

73.3 (5.7)

65–74

1,979

57.6%

1.3%

75+

1,701

42.4%

1.3%

Men

1,866

44.6%

0.8%

Women

1,814

55.4%

0.8%

Non-Hispanic whites

2,338

83.5%

1.5%

Non-Hispanic blacks

615

8.0%

0.9%

Hispanics

635

5.8%

0.9%

Other

92

2.6%

0.5%

Sex

Race

Income
<138% FPLb

500

8.9%

0.6%

≥138% FPL

2,877

91.1%

0.6%

≤High school

2,269

54.7%

2.0%

>High school

1,404

45.3%

2.0%

Yes

2,071

60.7%

1.3%

Noc

1,609

39.3%

1.3%

0 or 1

1,139

35.7%

1.6%

2 or more

2,341

64.3%

1.6%

Education

Married or with partner

Co-morbidities

PHQ-9 Score

a

0–4

2,863

82.1%

0.8%

5–9

494

13.8%

0.6%

10–14

122

3.2%

0.3%

15–19

43

0.8%

0.1%

20–27

8

0.2%

0.1%

Weighted percent, accounted for sampling design, noncoverage,
and nonresponse
b
Federal Poverty Level, where 138% FPL is the Medicaid income
eligibility limit
c
Divorced, separated, never married, widowed

a mortality rate of 3.51 deaths per 100 person-years. The
mean QALY throughout the remaining lifetime was
12.3 years (10.3 years for men and 14.4 years for women).
Among U.S. adults aged 65 years and older, 82.1% of
participants had none or minimal depressive symptoms,
13.8% had mild depression, and 4.1% had MDD (ranging
from moderate to moderately severe to severe). Because
only 8 participants had a PHQ-9 score in the range of
severe depressive disorder (20 or higher), we combined
those with a PHQ-9 score of 20 or higher with those
having a PHQ-9 ranging from 15–19. Mean EQ-5D
scores decreased as the severity of depressive symptoms
increased and mortality rates increased with increasing
severity of depressive symptoms (Table 2). The mean
QALY also decreased in a predictable manner according
to the severity of depression. In particular, the QALY for
those with none/minimal, mild, moderate, and moderately severe to severe depression were 14.0, 7.8, 4.7, and
3.3 years, respectively.
When the severity of depression was categorized according to the MDD status, the QALY were 4.4 years for
persons with MDD and 12.7 years for persons without
MDD (Table 3). This represents a decrease in QALY of
8.3 years, or a loss of 65% QALY, for those with MDD as
compared to those without MDD. In subcategories of
MDD, QALY also decreased with a higher level of depressive severity. Specifically, moderate depression contributed a loss of 8.0 QALYs (63%), and moderately
severe to severe depression contributed a loss of 9.4
QALYs (74%).
Among persons without MDD, persons with mild depression had significantly lower QALY than those with
none or minimal depressive symptoms (7.8 vs. 14.0
QALYs), or a loss of 6.2 QALYs (44%) for those with
MDS as compared to those with none or minimal depressive symptoms. For those with any depression (having mild depression or MDD), QALY was 6.5 years.
Therefore, any depression contributed a loss of 7.6
QALYs (55%) as compared to those with none or minimal depressive symptoms.
The same patterns were noted in subgroups. Across
subgroups defined by age, sex, race/ethnicity, income,
education, marital status, and number of comorbidities,
persons with MDD had consistently lower QALYs than
persons without MDD and those with mild depression
had consistently lower QALYs than those with none or
minimal depressive symptoms (Fig. 1). The adverse impact of MDD and mild depression on QALY was 3–4
times larger for persons 65 to 74 years old than for persons 75 years old or older. Specifically, QALY losses due
to MDD were 16.9 and 4.7 years for persons 65–74 years
old and for persons 75+ years, respectively, and losses
due to mild depression were 17.0 and 3.6 years, respectively. Of note, the much larger QALY loss for younger
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Table 2 EQ-5D index, Mortality Rate, and Quality-adjusted Life Years (QALY) throughout remainder of lifetime by Depressive
Symptom Severity Categories, U.S. Adults Aged 65 Years and Older
EQ-5Da

PHQ-9 score

Depression severity categories

Number

0–27

Total

3,680

0.827

0–4

None-minimal

2,863

0.875

Mortality rateb

S.E.

QALYc

S.E.

0.005

3.51

0.18

12.3

1.1

0.004

2.99

0.18

14.0

1.4

S.E.

5–9

Mild

494

0.680

0.018

4.69

0.60

7.8

1.0

10–14

Moderate

122

0.482

0.038

4.97

1.11

4.7

0.7

15–27

Moderately severe/ severe

51

0.353

0.063

8.15

2.81

3.3

1.3

a

EQ-5D index, adjusted for age and sex in subgroups
b
Mortality rate per 100 person-years, adjusted for age and sex in subgroups
c
Quality-adjusted life years, adjusted for age and sex in subgroups

participants was mainly because younger participants
had a much larger QALY than older participants.
Compared to men, women had a significantly higher
prevalence of MDD and mild depression (Table 4). As illustrated in Fig. 1, women and men lost a similar number of QALYs due to MDD (7.4 and 7.5 years). The
QALY loss due to mild depression was higher for
women than for men (7.3 and 4.9 years), but the difference in QALY loss due to mild depression between men
and women was not statistically significant. With regard
to race/ethnicity, Non-Hispanic whites and NonHispanic blacks had a significant QALY loss due to
MDD (8.3 and 5.3 years) and MDS (6.1 and 4.5 years)
compared to their counterparts without MDD. For Hispanics, the QALY loss was statistically significant only
due to MDS (5.1 years). Although Hispanics with MDD
lost 4.9 QALYs, the loss was not statistically significant
compared to Hispanics without MDD.
Compared to their counterparts, significantly higher
depressive symptoms were also found among persons
who reported a lower income, lower educational
achievement, being divorced, separated, never married,
or widowed, and having two or more comorbidities
(Table 4). The QALY losses due to MDD and due to
mild depression were statistically significant for all subgroups according to income category, education

achievement, marital status, and number of comorbidities (Fig. 1).

Discussion
Depression is a prevalent condition that greatly impacts
both morbidity and mortality [1, 2, 7, 8]. Previous studies reported a significant burden of disease for MDD [7,
8], but this is the first study, to our knowledge, to estimate QALY according to the severity levels of depressive
symptoms. This study not only confirmed the significant
burden of disease for MDD among the U.S. elderly, but
also showed an incremental decrease in QALYs with an
increasing severity of depressive symptoms as well as
significant QALY loss due to mild depression. Specifically, individuals with higher (or more impaired) PHQ-9
scores had significantly fewer QALYs. These findings
were replicated according to demographic and socioeconomic subgroups.
Our findings indicate that even mild depression is associated with a substantial loss (44% or 6.2 years) in
QALY in the elderly. This loss was of a magnitude similar to having diabetes or heart disease [25]. Among persons 65 years and older, depressive symptoms below the
threshold for major depression have been shown to
cause a higher risk of progression to depression compared to non-depressed elderly, with greater medical

Table 3 Decrease in Quality-adjusted Life Years (QALY) throughout remainder of lifetime due to Major Depressive Disorder (MDD)
and to Mild Depression, U.S. Adults Aged 65 Years and Older
PHQ-9 score

Depression severity categories

Number

QALYa

S.E.

Lossb

S.E.

% Loss

0–9

No MDD

3,357

12.7

1.1

Ref

-

-

10–27

MDDc

173

4.4

0.9

8.3

1.2

65%

Subcategories of MDD
10–14

Moderate

122

4.7

0.7

8.0

1.1

63%

15–27

Moderately severe/severe

51

3.3

1.3

9.4

1.6

74%

0–4

None-minimal

2,863

14.0

1.4

Ref

-

-

5–9

Mild depression

494

7.8

1.0

6.2

1.3

44%

5–27

Mild depression or MDD

667

6.5

0.8

7.5

1.3

54%

a

Quality-adjusted life years (QALY) throughout remainder of lifetime, adjusted for age and sex in subgroups
b
Decrease in QALY for higher levels depressive symptoms vs. lower level depressive symptoms
c
Major depressive disorder (MDD)
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Fig. 1 Quality-Adjusted Life Years (QALY) Loss Due to Major Depressive Disorder (MDD) and Mild Depression, Overall and by Subgroups, U.S.
Adults Aged 65 Years and Older. Race: W = Non-Hispanic whites, B = Non-Hispanic blacks, H = Hispanics; Income: lo = <138% Federal Poverty Level
(FPL), hi = ≥138% FPL; Education: lo = high school or less, hi = greater than high school; Married: Yes = Married or with a partner, No = Widowed,
Divorced, Separated, or Never Married

burden, worsened functional status, and both poor subjective health status and social support associated with a
higher risk of poor outcome [29]. Mild depression also is

associated with chronic illness, and has been shown to
be a risk factor for cardiovascular mortality [30]. This
would be a particular concern in the elderly population
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Table 4 Percent with Mild Depression and Major Depressive Disorder (MDD), U.S. Adults Aged 65 Years and Older
No or minimal depression (N = 2,863)

Mild depression (N = 494)

Major Depressive disorder (N = 173)

Percenta

S.E.

Percenta

S.E.

Percenta

S.E.

82.1%

0.8%

13.8%

0.6%

4.1%

0.4%

65–74

82.0%

1.4%

14.2%

1.1%

3.8%

0.5%

75+

82.3%

1.1%

13.5%

1.0%

4.3%

0.5%

Total
Age

Sex
Men

86.5%

0.9%

10.2%

0.8%

3.3%

0.4%

Women

78.6%

1.2%

16.6%

1.0%

4.7%

0.6%

Non-Hispanic whites

82.6%

0.9%

13.5%

0.7%

3.8%

0.4%

Race

Non-Hispanic blacks

81.8%

1.6%

14.5%

1.3%

3.7%

0.8%

Hispanics

76.6%

1.9%

15.5%

1.4%

7.9%

1.1%

Other

78.7%

3.2%

15.4%

2.4%

5.9%

1.3%

Income
<138% FPLb

74.6%

1.7%

17.0%

1.4%

8.4%

0.9%

≥138% FPL

84.1%

0.9%

12.8%

0.7%

3.1%

0.4%

≤High school

79.0%

1.1%

15.6%

1.0%

5.4%

0.6%

>High school

85.9%

1.2%

11.5%

1.0%

2.6%

0.4%

Yes

85.6%

0.9%

11.5%

0.9%

2.9%

0.3%

Noc

76.6%

1.4%

17.4%

1.1%

6.0%

0.7%

0 or 1

86.4%

1.2%

11.7%

1.0%

2.0%

0.3%

2 or more

79.8%

1.0%

14.9%

0.8%

5.3%

0.6%

Education

Married or with partner

Co-morbidities

a

Weighted percent, accounted for sampling design, noncoverage, and nonresponse
b
Federal Poverty Level, where 138% FPL is the Medicaid income eligibility limit
c
Divorced, separated, never married, widowed

where co-morbidities tend to be more common. Even
participants characterized as having mild depressive
symptoms have reported serious difficulty with work,
home, or social activities related to their symptoms [31]
and older adults have reported worsened overall quality
of life [32].
The treatment for sub-threshold depression has not
been firmly established and, for the PHQ-9, the current
guideline is to recommend watchful waiting and a repeat
PHQ-9 at follow-up [15]. In 2009 the National Institute
for Clinical Excellence noted that one or more of the following interventions might be offered for persons with
mild depression: individual self-help based on the principles of cognitive behavioral therapy, computerized cognitive behavioral therapy, and/or a structured group
physical activity program [33]. At present, a randomized
controlled trial is underway to determine if counselling
with low-intensity cognitive behavioral interventions are
effective for mild depression [34].

Our study has a number of noteworthy limitations. First,
the PHQ-9 is not a clinical diagnostic tool for diagnosing
depression but has been most widely used as a screening
instrument for estimating the prevalence of depression in
the general population [15, 17]. This would generate
population estimates that were less accurate and reliable
compared to a clinical diagnosis or interview. Second, although the results show different amounts of QALY loss
due to MDD and mild depression across subgroups (such
as between men and women), the sample size was too
small to test any differences between subgroups. Third,
the NHANES did not include the preference-based
HRQOL questions. We used a mapping algorithm to obtain EQ-5D scores for respondents based on their answers
to the four Healthy Days questions. Therefore, estimates
of QALY loss would also likely be underestimated due to
regression toward the mean [35]. However, a previous
study that examined the bias of QALE estimates showed
that these underestimations were less than 2.5% [35].
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This study used a novel method to estimate mean
QALYs throughout the remainder of the lifetime for persons according to level of depressive symptoms. Our
analyses showed that QALY estimates were reliable even
with a small sample size of approximately 100. Because
QALY uses the health utility value to weight years of life
lived, it provides a means for calculating the economic
costs of depression and for analyzing the costeffectiveness of treatments, interventions, and policies
that target depression and its related risk factors [36,
37]. Furthermore, construction of a single index enables
the burden of disease attributable to mild depression
and MDD to be compared with other chronic conditions
and risky behaviors [25].

Conclusions
In conclusion, among the U.S. elderly, as the severity of
depressive symptoms increased, the burden of disease attributable to depression became greater. Our findings of
fewer years of QALY for persons with MDD and mild
depression were not only statistically significant but also
clinically important. These findings have profound implications not only for clinicians but also for public health
authorities when setting health priorities and dealing
with mental health problems among the elderly population. Given the aging of the U.S. population and the high
prevalence of mild depression and MDD, investigators
should continue to develop prevention efforts for at-risk
elderly as well as effective interventions among persons
with a diagnosis of depression.
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